Our providers have experience with a variety of injectable, oral, and infusion treatments for MS and in treating a variety of neuroimmunological conditions. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.
Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS and other neuroimmunological conditions, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.
Duke Neurology at AAN 2023: Highlights from Boston
Members of the Duke Neurology Department shared their advances and insights in neurology education, health disparities, movement disorders, and other areas at the American Academy of Neurology’s (AAN) 75th annual meeting in Boston this week. This year, our faculty, staff, and trainees contributed more to the AAN than in any previous year, contributing to 20 posters and abstracts and six classes or sessions.
Duke Neurology Faculty, Trainees Stand Out at NCNS 2023
Winning the North Carolina Neurological Society's (NCNS) first NeuroBowl trivia contest was just the start for members of the Duke Neurology Department at the NCNS' 2023 annual meeting in Pinehurst, NC, this weekend.
Staff Spotlight: Elizabeth Blackwell
Today is National Women Physician’s Day. This day was marked to honor the birthday of Elizabeth Blackwell, the first woman allowed to enter medical school in the United States. Despite being forced to sit in separately in lectures, being excluded from labs, and facing other forms of discrimination Blackwell graduated first in her class in 1849, and went on to a long and distinguished career, improving physician handwashing, opening the New York Infirmary for Women and Children, and training nurses for Union hospitals during the Civil War.
Duke Neurology Research Round Up, January 2023
The final month of 2022 saw the release of 12 new peer-reviewed journal articles written or co-written by members of the Duke Neurology Department. Highlights of our most recent publications include an evaluation of a training program designed to improve the delivery of epilepsy care in Uganda, a review of recent advances in the treatment of carpal tunnel syndrome, and a discussion of treatment options for the autoimmune condition known as neuromyelitis optica spectrum disorder (NMOSD).
Duke Neurology 2022: A Year in Review (Part 2 of 2)
The Duke Neurology Department continued to build on its success in the second half of 2022. The final six months of 2022 saw Duke University Hospital receive national rankings for neurology and neurosurgery, our first endowed professorship dedicated to help treat and understand amyotrophic lateral sclerosis (ALS), and recognition as the country’s second national center of excellence for dystonia among other achievements.
Duke Neurology 2022: A Year in Review (Part 1 of 2)
The Duke Neurology Department continued to grow and advance its missions of patient care, research, and training the next generation of neurology providers in 2022. Highlights from the first half of our calendar year include national and Duke-wide awards recognizing our faculty’s contributions to the field of diversity, inclusion, and neurology as a whole. The same period also saw the growth of the new Duke/UNC Alzheimer’s Disease Research Center and three of our neurologists don helmets and get in their racing care.
Duke Neurology Research Round Up, December 2022
Members of the Duke Neurology Department advanced the fields of clinical and translational neuroscience this November, contributing to 16 new peer-reviewed studies.
Staff Spotlight: Debbie Dahnke, RN
For almost eight years, Debbie Dahnke, RN, worked in the Duke University Hospital’s neuro step down unit, helping some of the most intensely injured patients in DUH transition from neurocritical care to the next stage of their medical journey. Now as one of our research nurse coordinators, she’s helping to enroll and care for patients involved in our clinical trials for multiple sclerosis (MS) and status epilepticus. For this week’s Spotlight interview, Dahnke talks to us about how a friend with MS inspired her to become a nurse.
Duke Neurology Research Round Up, September 2022
Members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles published this August. Highlights include a review article examining evoked potentials used for deep brain stimulation in Parkinson’s, the healthcare received by veterans with epilepsy, the optimal stroke treatments for patients with cerebral venous thrombosis, and other topics.
Resident Spotlight: Danelvis Paredes, MD, MPH
Danelvis Paredes, MD, MPH, felt her first callings to neurology at the age of 15, when she learned about the neurobiology of drug addiction while working at a college laboratory. Later, that interest was cemented after she saw how a neurology exam could elegantly and quickly localize patients’ problems. For this week’s Spotlight interview, Paredes talks to us about her day-to-day life as a chief resident and how her master’s in public health influences her perspective as a clinician.